Taken together, this study provided a plausible anticancer mechanism of benzochalcone analogues as compared with our previous work and confirmed that KL-6 could serve as a new starting point for the development of drug candidates for gastric cancer therapy. This evidence concerns the gene MUC1 and gastric cancer.